Lamivudine Tablet, Film Coated
Product Images NDC 31722-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 31722-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudinestructure (Lamivudinestructure)

Lamivudinestructure (Lamivudinestructure)
Chemical structure of lamivudine, showing the molecular arrangement typical for this antiviral agent.*
FDA Label Image

Lamivudinetabs100mg (Lamivudinetabs100mg)

Lamivudinetabs100mg (Lamivudinetabs100mg)
Label for Lamivudine Tablets USP (HBV) 100 mg film-coated tablets by Camber Pharmaceuticals, Inc. The package contains 60 tablets and is for oral use. The label includes storage instructions (20° to 25°C), a U.S. contact number, manufacturer information indicating Annora Pharma Pvt. Ltd. in India, and a barcode with NDC 31722-001-60.*
FDA Label Image

Logocamber (Logocamber)

FDA Label Image

Logocamber2 (Logocamber2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.